DK3286198T3 - Forbindelser til behandling af pruritiske tilstande - Google Patents

Forbindelser til behandling af pruritiske tilstande Download PDF

Info

Publication number
DK3286198T3
DK3286198T3 DK16784019.8T DK16784019T DK3286198T3 DK 3286198 T3 DK3286198 T3 DK 3286198T3 DK 16784019 T DK16784019 T DK 16784019T DK 3286198 T3 DK3286198 T3 DK 3286198T3
Authority
DK
Denmark
Prior art keywords
compounds
treatment
pruritic conditions
pruritic
conditions
Prior art date
Application number
DK16784019.8T
Other languages
English (en)
Inventor
Amale Hawi
Original Assignee
Trevi Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trevi Therapeutics Inc filed Critical Trevi Therapeutics Inc
Application granted granted Critical
Publication of DK3286198T3 publication Critical patent/DK3286198T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK16784019.8T 2015-04-23 2016-04-22 Forbindelser til behandling af pruritiske tilstande DK3286198T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562151618P 2015-04-23 2015-04-23
PCT/US2016/029024 WO2016172613A1 (en) 2015-04-23 2016-04-22 Compounds for treating pruritic conditions

Publications (1)

Publication Number Publication Date
DK3286198T3 true DK3286198T3 (da) 2021-05-03

Family

ID=57144302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16784019.8T DK3286198T3 (da) 2015-04-23 2016-04-22 Forbindelser til behandling af pruritiske tilstande

Country Status (15)

Country Link
US (1) US9624233B2 (da)
EP (1) EP3286198B1 (da)
JP (1) JP6744327B2 (da)
AU (1) AU2016252892B2 (da)
CA (1) CA2981625C (da)
CY (1) CY1124163T1 (da)
DK (1) DK3286198T3 (da)
ES (1) ES2867799T3 (da)
HR (1) HRP20210606T1 (da)
HU (1) HUE054399T2 (da)
LT (1) LT3286198T (da)
PL (1) PL3286198T3 (da)
PT (1) PT3286198T (da)
SI (1) SI3286198T1 (da)
WO (1) WO2016172613A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111116597A (zh) * 2018-10-31 2020-05-08 扬子江药业集团江苏紫龙药业有限公司 一种纳布啡游离碱的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477456A (en) * 1981-07-02 1984-10-16 E. I. Du Pont De Nemours And Company Octahydro-4A,7-ethano- and -etheno-benzofuro[3,2-e]isoquinoline derivatives having analgesic, narcotic antagonist and anorexigenic properties
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
EP3064503A1 (en) * 2007-03-29 2016-09-07 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof

Also Published As

Publication number Publication date
LT3286198T (lt) 2021-07-12
US9624233B2 (en) 2017-04-18
EP3286198A1 (en) 2018-02-28
CY1124163T1 (el) 2022-05-27
AU2016252892B2 (en) 2019-05-02
AU2016252892A1 (en) 2017-10-26
SI3286198T1 (sl) 2021-08-31
JP6744327B2 (ja) 2020-08-19
CA2981625C (en) 2023-05-23
HUE054399T2 (hu) 2021-09-28
HRP20210606T1 (hr) 2021-05-28
EP3286198B1 (en) 2021-02-24
ES2867799T3 (es) 2021-10-20
US20160311832A1 (en) 2016-10-27
EP3286198A4 (en) 2018-09-26
PT3286198T (pt) 2021-04-26
JP2018513174A (ja) 2018-05-24
WO2016172613A1 (en) 2016-10-27
PL3286198T3 (pl) 2021-09-06
CA2981625A1 (en) 2016-10-27

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3349758T3 (da) Fremgangsmåder til behandling af arenaviridae-virusinfektioner
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3492632T3 (da) Metoder til behandling af lithiumholdige materialer
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3524255T3 (da) Sammensætning til behandling af acne
DK3186244T3 (da) Dioxolananaloger af uridin til behandling af cancer
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3359522T3 (da) Proces til fremstilling af N-Boc-bifenylalaninol
DK3318115T3 (da) Maskine til behandling af svinegylle
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner